Form 4: Pfizer CEO Bourla Acquires Phantom Stock Units
Statement of Changes in Beneficial Ownership
Pfizer Inc. Chairman and CEO Albert Bourla acquired 25 phantom stock units as part of a deferred compensation plan.
Summary
- Albert Bourla, Chairman and CEO of Pfizer Inc. (PFE), acquired 25 phantom stock units on October 15, 2025.
- The phantom stock units were acquired at a price of $24.39 per unit.
- Following this transaction, Bourla beneficially owns a total of 731,111 phantom stock units.
- These units are part of the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan.
- Each unit represents one phantom share of common stock and is settled in cash upon the reporting person's separation from service.
- The reporting person has the option to transfer these units into an alternative investment account at any time.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as it reflects continued executive participation in a long-term compensation plan, aligning management's interests with shareholders. However, the transaction size is very small relative to the company's scale, limiting its overall impact.
Positives
- The acquisition of phantom stock units by the Chairman and CEO demonstrates continued participation in the company's deferred compensation plan, aligning management's long-term interests with shareholder value.
- The transaction is part of a structured compensation plan, indicating stability in executive remuneration practices.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This transaction is a routine executive compensation event specific to Pfizer Inc. and does not provide broader insights into industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: The transaction indicates continued alignment of the CEO's long-term financial interests with the company's performance through a deferred compensation plan.
- Employees: The transaction is part of an executive compensation structure, which may influence broader compensation philosophies within the company.
Key Dates
| Date | Description |
|---|---|
| 10/15/2025 | Date of transaction for the acquisition of phantom stock units. |
| 10/17/2025 | Date the Statement of Changes in Beneficial Ownership (Form 4) was filed. |
Keywords
Pfizer, PFE, Albert Bourla, Phantom Stock Units, Deferred Compensation, Insider Transaction, SEC Form 4, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.